VYNE Therapeutics Files 2024 10-K
Ticker: VYNE · Form: 10-K · Filed: Mar 6, 2025 · CIK: 1566044
| Field | Detail |
|---|---|
| Company | Vyne Therapeutics Inc. (VYNE) |
| Form Type | 10-K |
| Filed Date | Mar 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, pharmaceutical, financials
TL;DR
VYNE Therapeutics filed its 2024 10-K, detailing financials and operations for the year ending Dec 31, 2024.
AI Summary
VYNE Therapeutics Inc. filed its 2024 10-K on March 6, 2025, reporting on its fiscal year ending December 31, 2024. The company, previously known as Menlo Therapeutics Inc. and Tigercat Pharma, Inc., is based in Bridgewater, New Jersey. The filing details its financial performance and business operations for the year.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of VYNE Therapeutics' financial health and strategic direction for the fiscal year 2024.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, VYNE Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- VYNE Therapeutics Inc. (company) — Filer of the 10-K
- Menlo Therapeutics Inc. (company) — Former name of VYNE Therapeutics Inc.
- Tigercat Pharma, Inc. (company) — Former name of VYNE Therapeutics Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-03-06 (date) — Filing date
- Bridgewater, New Jersey (location) — Company address
FAQ
What was VYNE Therapeutics' fiscal year end?
VYNE Therapeutics' fiscal year end was December 31, 2024.
When was the 10-K filing submitted?
The 10-K filing was submitted on March 6, 2025.
What are some former names of VYNE Therapeutics Inc.?
Former names include Menlo Therapeutics Inc. and Tigercat Pharma, Inc.
Where is VYNE Therapeutics Inc. located?
VYNE Therapeutics Inc. is located at 685 Route 202/206 N., Suite 301, Bridgewater, NJ 08807.
What is the Standard Industrial Classification for VYNE Therapeutics Inc.?
The Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on March 6, 2025 regarding VYNE Therapeutics Inc. (VYNE).